Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trial

BACKGROUND: Kidneys from deceased donors are being used to meet the growing need for grafts. However, delayed graft function (DGF) and acute rejection incidences are high, leading to adverse effects on graft outcomes. Optimal induction intervention should include both renal structure injury repair a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Transl Med
Hlavní autoři: Sun, Qipeng, Huang, Zhengyu, Han, Fei, Zhao, Ming, Cao, Ronghua, Zhao, Daqiang, Hong, Liangqing, Na, Ning, Li, Heng, Miao, Bin, Hu, Jianmin, Meng, Fanhang, Peng, Yanwen, Sun, Qiquan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5842532/
https://ncbi.nlm.nih.gov/pubmed/29514693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1422-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky